Us Bancorp \De\ Immunity Bio, Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.53 - $6.41 $745 - $3,121	487 Added 39.82%	1,710 $4,000
Q1 2023 May 09, 2023	BUY	$1.35 - $4.78 $117 - $415	87 Added 7.66%	1,223 $2,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $3,532 - $5,497	812 Added 250.62%	1,136 $5,000
Q1 2022 May 11, 2022	SELL	$5.05 - $7.53 $1,323 - $1,972	-262 Reduced 44.71%	324 $2,000
Q4 2021 Feb 11, 2022	SELL	$5.67 - $10.18 $11,340 - $20,360	-2,000 Reduced 77.34%	586 $4,000
Q3 2021 Nov 10, 2021	SELL	$9.17 - $14.24 $12,819 - $19,907	-1,398 Reduced 35.09%	2,586 $25,000
Q1 2021 Apr 28, 2021	BUY	$12.83 - $42.25 $51,114 - $168,324	3,984 New	3,984 $95,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.09B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.